Table 3.
Clinical status of patients with and without viruses at pulmonary exacerbation.
Virus-positive |
Virus-negative |
p value | |
---|---|---|---|
(n = 26) | (n = 17) | ||
Predicted FEV1a | 17 (65.4) | 15 (88.2) | 0.447 |
– Median (IQRb) | 48 (39.5–64.8) | 60 (44–79) | 0.213 |
Received antibiotics | 18 (69.2) | 11 (64.7) | 0.335 |
Hospitalized | 9 (34.6) | 5 (29.4) | 0.504 |
CFCSc | 25 (96.1) | 16 (94.1) | 0.234 |
– Mean (range) – Median (IQR) |
27.2 (19–39) | 23.7 (17–41) | 0.061 |
27 (18–30) | 24 (18–27) | 0.041 | |
CFQ-Rd (physical) | 18 (69.2) | 15 (88.2) | 0.405 |
– Mean (range) – Median (IQR) |
58.3 (33.3–78.2) 53.4 (0–100) |
79.2 (61.1–91.7) 75.3 (11.1–100) |
0.028 0.030 |
Sputum IL-8 | 11 (42.3) | 6 (35.3) | 0.386 |
– Median (IQR), pg/ml | 1785.8 (779–2936.9) | 1403 (336–2448.5) | 0.615 |
Sputum neutrophil percentage | 11 (42.3) | 5 (29.4) | 0.553 |
– Median (IQR) | 99.5 (99.3–99.9) | 99. 3 (99–99.5) | 0.402 |
Sputum neutrophil count | 11 (42.3) | 5 (29.4) | 0.553 |
– Median (IQR), μ/ml | 398 (397–399) | 398 (396–399.5) | 0.863 |
Sputum neutrophil elastase | 11 (42.3) | 6 (35.3) | 0.386 |
– Median (IQR), μ/ml | 0.2 (0.1–0.3) | 0.3 (0.1–0.5) | 0.421 |
Sputum total bacterial density | 8 (30.8) | 7 (41.2) | 0.449 |
– Mean (SD)e, colony forming units/mL | 3.9 × 107 (6.9 × 107) | 1.8 × 109 (4.5 × 109) | 0.299 |
Staphylococcus aureus bacterial density | 5 (19.2) | 5 (29.4) | 0.350 |
– Mean (SD), colony forming units/mL | 1.3 × 107 (2.6 × 107) | 5.9 × 107 (8.0 × 107) | 0.249 |
Pseudomonas aeruginosa bacterial density | 2 (7.7) | 2 (11.8) | 0.261 |
– Mean (SD), colony forming units/mL | 1.3 × 108 (1.0 × 108) | 6.0 × 109 (8.5 × 109) | 0.431 |
Haemophilus influenzae bacterial density | 1 (3.8) | – | – |
Note. Data are n (%) unless otherwise indicated. * No observations.
Forced expiratory volume in one second at exacerbation.
Interquartile range (25th–75th percentile).
Cystic fibrosis clinical score.
Cystic Fibrosis Questionnaire-Revised.
Standard deviation.